Frailty Exacerbates Disability in Progressive Multiple Sclerosis
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks +10 more
wiley +1 more source
Large language models and conditional rules in clinical decision support systems. [PDF]
Sivasothy S +8 more
europepmc +1 more source
The Competition Effect in a Public Procurement Model : An error-in-variables approach
David Sundström
openalex +1 more source
Sieve maximum likelihood estimation in a semi-parametric regression model with errors in variables
Denis Belomestny +2 more
openalex +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Spatiotemporal trends and machine learning-based prediction of temperature variability during the T. Aman rice-growing season in Bangladesh. [PDF]
Rahman NMF +8 more
europepmc +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Non-motor symptoms as critical predictors of quality of life in Parkinson's disease: a machine learning approach. [PDF]
Magano D +4 more
europepmc +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Miyake Revisited: Validating the Factor Structure of an Open-Source Cognitive Control Test Battery. [PDF]
Demeyer F +6 more
europepmc +1 more source

